Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

[1]  A. Thanopoulou,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[2]  N. Marchionni,et al.  Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[3]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[4]  H. Gerstein.  Is it possible to reduce cardiovascular risk with glucose-lowering approaches? , 2009, Nature Reviews Endocrinology.

[5]  J. R. Lee,et al.  Association of Hemoglobin A1c with Cardiovascular Disease Risk Factors and Metabolic Syndrome in Nondiabetic Adults , 2008 .

[6]  R. Califf,et al.  Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. , 2008, American heart journal.

[7]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[8]  H. Gerstein,et al.  Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). , 2008, American heart journal.

[9]  S. Yusuf,et al.  Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk , 2007, Circulation.

[10]  Janet E Hux,et al.  Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study , 2007, The Lancet.

[11]  L. Rydén,et al.  Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. , 2006, European heart journal.

[12]  D. Hu,et al.  The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. , 2006, European heart journal.

[13]  C. Patterson,et al.  Diabetes Atlas (3rd edition) , 2006 .

[14]  Martin J Shipley,et al.  Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. , 2006, Diabetes care.

[15]  A. Folsom,et al.  Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. , 2005, Archives of internal medicine.

[16]  M. Woodward,et al.  Blood glucose and risk of cardiovascular disease in the Asia Pacific region. , 2004, Diabetes care.

[17]  Roberto Ferrari,et al.  The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.

[18]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[19]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[20]  S. Yusuf,et al.  Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[21]  J. Tuomilehto,et al.  Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.

[22]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[23]  T. Stevenson.  Glycosal: the first rapid, point-of-care test for the determination of hemoglobin A1c in patients with diabetes. , 1999, Diabetes technology & therapeutics.